Global New Product Planning Lead - Diabetes&, Early Pipeline & External Innovation

The science of diabetes, cardiorenal disease and the role of inflammation is being rewritten. Be the commercial mind that shapes which breakthroughs reach patients.

Your new role

Most people with deep expertise in cardiovascular disease, chronic kidney disease, or inflammatory therapeutics spend their careers generating insight for others to act on. This role is different. As New Product Planning Lead, your clinical and commercial understanding of cardiorenal and inflammatory diseases will directly drive the investment decisions that determine whether tomorrow's most innovative assets get developed and reach patients.

This is a role built for exceptional thinkers from a range of backgrounds – PhD scientists ready to apply their depth to commercial strategy, strategy consultants who want to own outcomes rather than advise on them, or healthcare equity analysts who want to drive pipeline decisions from the inside.

Your responsibilities will include:

• Building business cases, risk-adjusted valuations, and indication sequencing models that feed directly into governance investment decisions across the cardiorenal and inflammatory portfolio
• Developing and validating Target Product Profiles through structured KOL interviews with leading cardiologists, nephrologists, endocrinologists, and specialist Multi-disciplinary team members – challenging commercial thresholds against real clinical practice
• Mapping patient flows, referral networks, care transitions, and novel biomarker adoption dynamics to identify commercial opportunities and portfolio gaps – including for asymptomatic and subpopulation-targeted strategies
• Ensuring product strategies reflect the access realities of specialist and hospital settings – formulary dynamics, managed entry, pharmacist roles, and cardiovascular reimbursement pathways
• Contributing to RWE strategy design and applying real-world data assets to sharpen forecasting and commercial planning
• Supporting Business Development assessments with commercial perspective on asset fit and value creation potential

Your new department

In Product & Portfolio Strategy we drive commercial strategy, medical affairs and business development across all therapy areas – acting as the connector between scientific innovation and commercial impact across the Novo Nordisk portfolio.

The Diabetes& Early Pipeline & External Innovation team works at the frontier of cardiometabolic medicine – across novel modalities, biologies, and value propositions – in disease areas where the metabolic, cardiorenal, and inflammatory science and the commercial landscape are both evolving at pace. We challenge each other's thinking, share our work openly, and hold ourselves to the highest standards of analytical quality. We don't have all the answers – and we're looking for someone who finds that exciting rather than unsettling.

Your skills & qualifications

We’re looking for someone with genuine scientific or analytical depth applied to the commercial challenges of one of the most diverse and exciting portfolios in cardiometabolic medicine. You’re intellectually curious, thrive in ambiguity, and want your work to directly influence which medicines reach patients.

You will bring:

• A Master’s or PhD in Economics or Business with strong natural science capabilities (Life Sciences PhD strongly preferred), or a Master’s/PhD in Medicine, Biology, or Pharmacy with strong commercial understanding, or an advanced degree with a healthcare equity analyst or investment banking background
• 4–6 years of pharmaceutical industry experience in New Product Planning, global marketing, medical affairs, market access, or strategy consulting
• Disease area experience in Cardiovascular or Inflammatory disease areas, paired with strong financial modelling capability (discounted cash flows, scenario analysis, risk-adjusted valuations), built in pharma, consulting, or investment banking environments
• Experience in patient flow modelling, forecasting, and quantitative business case development
• Familiarity with clinical realities in these patient populations, including cardiotoxicity and infection risk management, haemostasis in unstable cardiorenal patients, treatment intensification protocols, care transitions, or novel biomarker strategies
• Comfort operating at the interface of clinical science and commercial strategy
• Ability to influence without formal authority in a complex matrix organisation
• Fluency in English

Working at Novo Nordisk

For over 100 years, we've been dedicated to driving lasting change for long-term health. Today, that dedication fuels our work at the frontier of cardiometabolic medicine – where scientific breakthroughs and commercial strategy come together to determine which innovations reach patients. We approach every challenge with curiosity and rigour, knowing that diverse thinking and bold questions lead to better outcomes. Here, your expertise won't just inform decisions – it will shape them. When you join us, you become part of a story that spans generations, working alongside people who share your commitment to creating change that lasts.

What we offer

Being part of a global healthcare company means opportunities to learn and develop are all around us. You'll work with some of the most exciting science in cardiometabolic medicine, collaborate with experts across disciplines, and see your analytical work translate directly into investment decisions that impact millions of patients. Our benefits are designed with your career and life stage in mind, supporting you to thrive both professionally and personally.

Deadline for applications: 13 May 2026
Applications are reviewed on an ongoing basis.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and preventing diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.